An EP clinic with 400 active ICM patients will generate somewhere between 80 and 300 remote transmissions in a given week. That number sounds manageable until you consider that roughly four out of every five of those transmissions will contain nothing actionable: sinus rhythm with minor rate variation, artifact flagged as a pause, or an AF burden episode well below the clinic's intervention threshold. The transmissions arrive anyway, tagged with the same visual urgency as the ones that matter.
Alert fatigue is not primarily a technology problem. It is a volume-to-attention problem. When a device coordinator opens the Merlin.net or CareLink queue on a Monday morning and finds 60 unreviewed transmissions stacked from the weekend, the cognitive demand of working through them one by one is not just a time burden. It introduces selection pressure: the reviewer starts making faster judgments per item to clear the queue. The transmissions at position 47 and 53 receive less attention than position 2.
This is not negligence. It is a predictable human response to workload that outpaces the time available to address it. Published data from remote cardiac monitoring studies consistently show that clinics with high ICM panel sizes experience 6 to 14 day delays between transmission receipt and physician review. At a device coordinator level, the lag is often shorter, but the triage quality under volume pressure is the variable no one measures.
The three major manufacturer platforms — Merlin.net (Abbott), CareLink (Medtronic), and Home Monitoring Service (Biotronik) — present transmissions in a queue format sorted primarily by receipt time or device model. None of them, by default, present the coordinator with a ranked view based on clinical urgency derived from the patient's history, current medications, or recent prior transmissions.
That means a transmission containing an 8-second asystolic pause in a patient with no prior pauses sits in the same visual tier as a transmission from a patient whose device fires AF burden alerts every 11 days like clockwork because their permanent AF is managed conservatively and the threshold has never been adjusted. Both arrive. Both display an alert tag. Neither the platform nor the queue tells the coordinator which one should have eyes on it in the next 15 minutes versus the next three business days.
In a 4:1 benign-to-actionable ratio, one in five transmissions warrants some form of clinical response — a note update, a medication change, an expedited visit, or a same-day call. In a clinic running 200 transmissions per week, that is 40 actionable items. The problem is that identifying which 40 requires reviewing all 200 first.
Without a mechanism to surface the 40 before the coordinator has manually processed all 200, the standard workflow forces full sequential review. Device coordinators managing panels of this size regularly report spending three to five hours each morning on transmission review before doing anything else. Afternoon transmissions that arrive after the morning processing window can sit until the next day. If the clinic has a particularly heavy Monday — common because devices transmit automatically on scheduled days and many are programmed to transmit weekly — the queue can take until Wednesday to fully clear.
A counterintuitive finding in alert fatigue research is that increasing the sensitivity of automated flags — generating more alerts to catch more potential events — tends to worsen the problem. When the false positive rate is already high, adding alerts shifts the signal-to-noise ratio further toward noise. Coordinators habituate to alert states. Platforms that flag 70% of transmissions with some color-coded indicator train reviewers to discount the indicator.
Effective alert fatigue reduction requires the opposite approach: reducing the total number of flagged items by improving specificity, not sensitivity. That means incorporating patient-level clinical context — diagnosis, indication for ICM implant, prior transmission history, current antiarrhythmic regimen, and documented thresholds — into the classification logic. A 2.1% AF burden episode in a patient implanted for cryptogenic stroke with no prior AF history is a very different finding than the same episode in a patient with long-standing persistent AF who is already on anticoagulation and whose physician has set a 5% threshold for review.
Coordinator time consumed by low-yield transmissions is a concrete operational cost. A clinic paying a certified device coordinator at typical market rates, where that coordinator spends three hours daily on transmission review, is allocating somewhere between 35% and 50% of that coordinator's clinical capacity to remote monitoring review alone. Clinics that try to control this cost by reducing coordinator headcount discover that panel sizes grow faster than per-coordinator capacity. Clinics that add coordinators discover that the queue generates more work proportionally as the panel grows.
The structural answer is not more staff for the same workflow. It is a workflow that distinguishes, before any human review begins, which transmissions are likely to require action and which are likely to be benign — and presents them accordingly. Implansense builds exactly that layer: a risk stratification and alert classification module that sits between the manufacturer platforms and the coordinator's review queue, reducing the proportion of transmissions requiring full review without suppressing clinically relevant findings.
No classification system eliminates false positives entirely. The goal at a clinic managing 200 weekly transmissions is not to reduce the review burden to zero — it is to make the 40 actionable items clearly identifiable before the coordinator has invested three hours in the full queue. A system that achieves 70% specificity on benign-transmission filtering while maintaining high sensitivity for actionable findings represents a meaningful reduction in coordinator burden without introducing clinical risk from missed findings.
Alert fatigue in EP clinics is a solvable problem. It requires taking the transmission volume seriously as a structural constraint, not a temporary inconvenience, and building review workflows around the reality that the majority of what arrives is benign — and that majority should be handled accordingly.
